Fundz

Tubulis Raises €308 Million Series C to Accelerate Clinical Development of TUB-040 and Expand Pipeline, led by Venrock Healthcare Capital Partners.

PRIVATEOct 15, 2025

Amount Raised

€308 Million

Round Type

Series C

MunichBiotechnologyHealth Care

Investors

Andera PartnersDeep Track CapitalHigh Tech GründerfondsSeventure PartnersBayern KapitalWellington ManagementAscenta CapitalNextech InvestEQT Life SciencesFrazier Life SciencesFund+OccidentVenrock Healthcare Capital Partners

Description

Tubulis announced the successful closing of a €308 million financing round led by Venrock Healthcare Capital Partners, with participation from Wellington Management and Ascenta Capital. The funds will be used to expand the clinical development of TUB-040, their lead ADC candidate, into earlier therapy lines and additional tumor indications. The capital will also advance Tubulis’ pipeline, including TUB-030 and other preclinical programs. This financing round demonstrates strong investor conviction in Tubulis' innovative ADC platforms.

Quick answer

Tubulis raised €308 Million in a Series C round, dated October 15, 2025. Investors: Andera Partners, Deep Track Capital, High Tech Gründerfonds, Seventure Partners, Bayern Kapital, Wellington Management, Ascenta Capital and Nextech Invest. Tubulis is based in Munich, Bavaria, Germany.

How much did Tubulis raise?
Tubulis raised €308 Million in a Series C round on October 15, 2025.
Who invested in Tubulis?
Andera Partners, Deep Track Capital, High Tech Gründerfonds, Seventure Partners, Bayern Kapital, Wellington Management, Ascenta Capital and Nextech Invest are named as investors in this round.
What does Tubulis do?
Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology.
Where is Tubulis based and how big is it?
Tubulis is based in Munich, Bavaria, Germany. Fundz records about 73 employees.
Who are the decision-makers at Tubulis?
Fundz holds 1 contact at Tubulis. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Tubulis that raised within 45 days of this round, from Fundz verified event records.

  • Healthplus.ai raised $2.7M (Seed) on November 29, 2025.
  • Azora Therapeutics, Inc. (DE) raised $4.3M on November 28, 2025.
  • Medow Health raised $2.2M (Funding Round) on November 27, 2025.
  • Noteless raised $4.1M (Seed) on November 27, 2025.
  • Ventuno Biotech raised $3.5M (Seed) on November 27, 2025.
  • Gosta Labs raised $8.7M (Seed) on November 27, 2025.

Who to call at Tubulis, and when

A new round usually means Tubulis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Tubulis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Tubulis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Tubulis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Tubulis

Location

Munich, Bavaria, Germany

About

Tubulis® generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. We will advance a range of conjugates, unlimited by indication, using our own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Tubulis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Tubulis's next move

See what Strategic adds

Tubulis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.